Pfizer Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is 0.42% vs 6.52% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -24.96% vs -1.42% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -0.76% vs 9.48% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is -6.57% vs -34.46% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Pfizer With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

645.03

1,177.51

-532.48

-45.22%

Other Operating Income

0.00

Total Operating income

645.03

1,177.51

-532.48

-45.22%

Raw Material Cost

67.78

434.85

-367.07

-84.41%

Purchase of Finished goods

145.15

1.50

143.65

9,576.67%

(Increase) / Decrease In Stocks

11.84

27.93

-16.09

-57.61%

Employee Cost

100.30

134.14

-33.84

-25.23%

Power Cost

0.00

29.54

-29.54

-100.00%

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

91.77

127.93

-36.16

-28.27%

Total Expenditure (Excl Depreciation)

416.84

755.89

-339.05

-44.85%

Operating Profit (PBDIT) excl Other Income

228.19

421.62

-193.43

-45.88%

Other Income

38.21

60.21

-22.00

-36.54%

Operating Profit (PBDIT)

266.40

481.83

-215.43

-44.71%

Interest

1.99

0.50

1.49

298.00%

Exceptional Items

-58.20

-24.35

-33.85

-139.01%

Gross Profit (PBDT)

206.21

456.98

-250.77

-54.88%

Depreciation

14.26

44.53

-30.27

-67.98%

Profit Before Tax

191.95

412.46

-220.51

-53.46%

Tax

50.11

104.61

-54.50

-52.10%

Provisions and contingencies

0.00

Profit After Tax

141.84

307.85

-166.01

-53.93%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

141.84

307.85

-166.01

-53.93%

Equity Capital

45.75

16.48

29.27

177.61%

Face Value

10.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

31.00

18.68

12.32

65.95%

Diluted Earnings per share

31.01

18.68

12.33

66.01%

Operating Profit Margin (Excl OI)

35.38%

35.81%

0.00

-0.43%

Gross Profit Margin

31.97%

38.81%

0.00

-6.84%

PAT Margin

21.99%

26.14%

0.00

-4.15%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 645.03 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 0.42% vs 6.52% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 19.90% vs -0.37% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 141.84 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -24.96% vs -1.42% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 11.16% vs -1.83% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 228.19 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -0.76% vs 9.48% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 56.31% vs -4.30% in Dec 2024

Quarterly - Interest

Interest 1.99 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -6.57% vs -34.46% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 31.79% vs -47.20% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 35.38%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024